Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001161697-18-000046
Filing Date
2018-01-16
Accepted
2018-01-16 11:47:59
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ANNUAL REPORT FOR 09-30-2017 form_10-k.htm 10-K 621959
2 SUBSIDIARIES OF THE REGISTRANT ex_21.htm EX-21 876
3 RULE 13A-14(A) CERTIFICATION ex_31-1.htm EX-31 5960
4 SECTION 1350 CERTIFICATION ex_32-1.htm EX-32 3618
5 GRAPHIC angiosoma_logo.jpg GRAPHIC 28901
6 GRAPHIC mk_cpas-logo.jpg GRAPHIC 7142
  Complete submission text file 0001161697-18-000046.txt   2780681

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE soan-20170930.xml EX-101.INS 337151
8 XBRL SCHEMA FILE soan-20170930.xsd EX-101.SCH 33294
9 XBRL CALCULATION FILE soan-20170930_cal.xml EX-101.CAL 48951
10 XBRL DEFINITION FILE soan-20170930_def.xml EX-101.DEF 109370
11 XBRL LABEL FILE soan-20170930_lab.xml EX-101.LAB 246705
12 XBRL PRESENTATION FILE soan-20170930_pre.xml EX-101.PRE 199186
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-55072 | Film No.: 18527910
SIC: 2834 Pharmaceutical Preparations